Corixa Corporation
Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington, involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Corixa Corporation, United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
48%
Total
Publications
261
Total Open
Publications
125
Total
Citations
21K
Open Access
Percentage
48%
Total
Publications
261
Total Open
Publications
125
Total
Citations
21K
Breakdown
Publisher Open
25%
Both
21%
Other Platform Open
3%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
50
Hybrid 4%
5
No Guarantees 55%
67
Other Platform Open
Domain 86%
56
Institution 26%
17
Other Internet 8%
5
Preprint 2%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 56 |
National Institutes of Health | Institution | 6 |
doaj.org OAI-PMH Repository | Institution | 6 |
LA Referencia | Institution | 3 |
DOI | Other Internet | 3 |
Unknown Repository | Other Internet | 2 |
University of Würzburg | Institution | 1 |
University of Michigan | Institution | 1 |
Queen's University Belfast | Institution | 1 |
arXiv | Preprint | 1 |